Clinical trials
Metabolic Syndrome trials in Brazil
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
33 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2007 | 3 |
| 2009 | 2 |
| 2010 | 2 |
| 2011 | 2 |
| 2012 | 1 |
| 2013 | 4 |
| 2014 | 2 |
| 2015 | 3 |
| 2016 | 1 |
| 2017 | 2 |
| 2018 | 1 |
| 2019 | 2 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 2 |
| 2025 | 2 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 23 |
| Unknown status | 6 |
| Enrolling by invitation | 2 |
| Not yet recruiting | 1 |
| Recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| University of Sao Paulo | 6 |
| Federal University of São Paulo | 5 |
| Hospital de Clinicas de Porto Alegre | 2 |
| University of Sao Paulo General Hospital | 2 |
| Centro Universitário de Anapolis | 1 |
| Faculdade de Ciências Médicas da Santa Casa de São Paulo | 1 |
| Federal University of Rio Grande do Sul | 1 |
| Hospital Moinhos de Vento | 1 |
| Hospital de Base | 1 |
| Kaiser Clinic and Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Metabolic Syndrome | 33 |
| Obesity | 13 |
| Insulin Resistance | 5 |
| Inflammation | 3 |
| Diabetes Mellitus | 2 |
| Dyslipidemias | 2 |
| Albuminuria | 1 |
| Atherosclerosis | 1 |
| Body Weight Changes | 1 |
| Diabetes Mellitus, Type 2 | 1 |
Trials
Showing 1 to 25 of 33. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.